Epitor

Epitor Therapeutics is advancing the next generation of epigenetic editors to treat diseases with high unmet need.

Our optimized technology uses CRISPR-Cas to target specific genes and modulate gene expression without editing underlying DNA and can target any organ of interest.

LEARN MORE
Learn more

CAREERS

We are looking for innovative thinkers and visionaries as we pave the way for the future of genomic medicine. Discover how you can contribute and make a lasting impact with us.

JOIN THE EPITOR TEAM Learn more

EPITOR THERAPEUTICS NEWS

Epitor Therapeutics Unveils CasNano: A Compact, All-in-One CRISPR/Cas for Single AAV Therapies at the American Society of Gene & Cell Therapy Annual Meeting

09 MAY, 2024

READ MORE

OUR TEAM

Megan McGill, MD, PhD

Megan McGill, MD, PhD

CEO, Board Member

Orrin Devinsky, MD

Orrin Devinsky, MD

COO, Board Member

Eva Essig, PhD

Eva Essig, PhD

Chief Regulatory Officer, Board Member

Shawn Liu, PhD

Shawn Liu, PhD

Chief Scientific Advisor

Michael Jasulavic

Michael Jasulavic

Board Member

Yong Chang

Yong Chang

Board Member

Asa Abeliovich, MD, PhD

Asa Abeliovich, MD, PhD

SAB Member

Xuebing Wu, PhD

Xuebing Wu, PhD

SAB Member

Kyle Fink, PhD

Kyle Fink, PhD

SAB Member

Woofung Tsai, PhD

Woofung Tsai, PhD

Associate Director, Research and Development

Dongkyeong Kim, PhD

Dongkyeong Kim, PhD

Senior Scientist

Chia-Wei Huang, PhD

Chia-Wei Huang, PhD

Senior Scientist

Patricia Tolete

Patricia Tolete

Director of Operations

WE ARE LOCATED AT

Alexandria LaunchLabs @ Columbia,
3960 Broadway 6th Floor,
New York, NY 10032

CONTACT US

info@epitortx.com